Catalyst Pharmaceutical Partners Inc buy StockNews.com
Start price
08.06.24
/
50%
€14.43
Target price
08.06.25
-
Performance (%)
24.60%
Price
07.10.24
€17.98
Summary
This prediction is currently active. The BUY prediction by StockNews_com currently has a performance of 24.60%. This prediction currently runs until 08.06.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 0.700% | 0.700% |
| iShares Core DAX® | -1.958% | 4.037% |
| iShares Nasdaq 100 | 0.272% | 8.670% |
| iShares Nikkei 225® | 0.377% | 7.232% |
| iShares S&P 500 | 0.370% | 6.511% |
Comments by StockNews_com for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for CPRX provided by MarketBeat